Literature DB >> 1493940

The role of GM-CSF in infection.

M Freund1, H D Kleine.   

Abstract

GM-CSF is a hemopoietic growth factor with substantial effects on the proliferation of neutrophils, eosinophils and monocytes/macrophages. Its physiologic role in infection is still poorly understood. The gene for GM-CSF is constitutively transcribed in cells substantial for antiinfectious response. Various cells are activated and induced by TNF and IL-1 to synthesize GM-CSF. No systemic GM-CSF levels can be detected in patients with infection. It is likely that GM-CSF plays its physiological role in the immediate vicinity of the cells by which it is secreted. GM-CSF functionally activates neutrophils, monocytes/macrophages and eosinophils. It may augment T-cell proliferation and function. GM-CSF is effective in mice infected with Staphylococcus aureus or Salmonella typhimurium. Its effect in infectious disease in man should be explored.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1493940     DOI: 10.1007/bf01705024

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  90 in total

1.  Humoral regulation of megakaryocytopoiesis.

Authors:  A Grossi; A M Vannucchi; P Rossi Ferrini
Journal:  Biotherapy       Date:  1990

2.  Ethanol augments intracellular survival of Mycobacterium avium complex and impairs macrophage responses to cytokines.

Authors:  L E Bermudez; L S Young
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

3.  Antibodies to GM-CSF.

Authors:  S Gillis; L Garrison
Journal:  Lancet       Date:  1990-05-19       Impact factor: 79.321

4.  Anti-bacterial activity of peritoneal cells from transgenic mice producing high levels of GM-CSF.

Authors:  H T Tran; D Metcalf; C Cheers
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

5.  Granulocyte-macrophage and macrophage colony-stimulating factors activate intramacrophage killing of Leishmania mexicana amazonensis.

Authors:  J L Ho; S G Reed; E A Wick; M Giordano
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

6.  The growth of mouse bone marrow cells in vitro.

Authors:  T R Bradley; D Metcalf
Journal:  Aust J Exp Biol Med Sci       Date:  1966-06

7.  Analysis in serum-free culture of the targets of recombinant human hemopoietic growth factors: interleukin 3 and granulocyte/macrophage-colony-stimulating factor are specific for early developmental stages.

Authors:  Y Sonoda; Y C Yang; G G Wong; S C Clark; M Ogawa
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

8.  Neutrophil migration is defective during recombinant human granulocyte-macrophage colony-stimulating factor infusion after autologous bone marrow transplantation in humans.

Authors:  W P Peters; A Stuart; M L Affronti; C S Kim; R E Coleman
Journal:  Blood       Date:  1988-10       Impact factor: 22.113

9.  Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator.

Authors:  R H Weisbart; D W Golde; S C Clark; G G Wong; J C Gasson
Journal:  Nature       Date:  1985 Mar 28-Apr 3       Impact factor: 49.962

10.  Human granulocyte-macrophage colony-stimulating factor purified from a Hodgkin's tumor cell line.

Authors:  P V Byrne; W F Heit; C J March
Journal:  Biochim Biophys Acta       Date:  1986-12-12
View more
  9 in total

Review 1.  Osteoblast responses to bacterial pathogens: a previously unappreciated role for bone-forming cells in host defense and disease progression.

Authors:  Ian Marriott
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  Granulocyte-macrophage colony-stimulating factor in Staphylococcus aureus-induced arthritis.

Authors:  M Verdrengh; A Tarkowski
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

3.  Induction of colony-stimulating factor expression following Staphylococcus or Salmonella interaction with mouse or human osteoblasts.

Authors:  K L Bost; J L Bento; J K Ellington; I Marriott; M C Hudson
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

4.  Functional CD40 expression induced following bacterial infection of mouse and human osteoblasts.

Authors:  Laura W Schrum; Ian Marriott; Betsy R Butler; Elaine K Thomas; Michael C Hudson; Kenneth L Bost
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

5.  Impact of Antifungal Compounds on Viability and Anti-Aspergillus Activity of Human Natural Killer Cells.

Authors:  Stanislaw Schmidt; Ralf Schubert; Lars Tramsen; Thomas Lehrnbecher
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

6.  Roles of tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, platelet-activating factor, and arachidonic acid metabolites in interleukin-1-induced resistance to infection in neutropenic mice.

Authors:  M T Vogels; C C Hermsen; H L Huys; W M Eling; J W van der Meer
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

7.  The effect of enzymatically polymerised polyphenols on CD4 binding and cytokine production in murine splenocytes.

Authors:  Daisuke Yamanaka; Yumi Tamiya; Masuro Motoi; Ken-ichi Ishibashi; Noriko N Miura; Yoshiyuki Adachi; Naohito Ohno
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

Review 8.  Apoptosis-associated uncoupling of bone formation and resorption in osteomyelitis.

Authors:  Ian Marriott
Journal:  Front Cell Infect Microbiol       Date:  2013-12-19       Impact factor: 5.293

9.  Prophylactic Administration of Vector-Encoded Porcine Granulocyte-Colony Stimulating Factor Reduces Salmonella Shedding, Tonsil Colonization, and Microbiota Alterations of the Gastrointestinal Tract in Salmonella-Challenged Swine.

Authors:  Shawn M D Bearson; Bradley L Bearson; Crystal L Loving; Heather K Allen; InSoo Lee; Darin Madson; Marcus E Kehrli
Journal:  Front Vet Sci       Date:  2016-08-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.